The first-in-man study, completed by a team of cardiologists in China, included 10 patients presenting with HFpEF. 

Joanna Chikwe, MD, founding chair of the department of cardiac surgery at Cedars-Sinai Hospital, compares transcatheter edge-to-edge repair (TEER) to mitral valve surgery for primary mitral regurgitation.

The increased risk of deep vein thrombosis lasts for up to three months, researchers found. 

Steven E. Nissen, MD, chief academic officer of the Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute at the Cleveland Clinic, was the lead author on the Apollo Trial, a late-breaking ACC.22 study evaluating the effectiveness of an mRNA drug to suppress lipoprotein(a).

An updated look at patients treated with Medtronic's renal denervation system was presented at ACC.22 and simultaneously published in The Lancet. 

Click through a wide variety of snapshots from ACC.22 in Washington, D.C. 

The authors hope their findings could lead to earlier diagnoses and improvements in patient care. 

Out of 50,000 men included in the study, 17.5% sustained a fracture after beginning prostate cancer treatment, but only 7.9% received such scans.

A study in Lancet Digital Health reports that a previously validated, high performing AI model committed troublesome errors when confronted with atypical anatomy.